Lawrence Biegelsen
Stock Analyst at Wells Fargo
(0.83)
# 3,644
Out of 4,670 analysts
56
Total ratings
41.94%
Success rate
-14.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $9.70 | +106.19% | 7 | Mar 14, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $20 → $17 | $4.52 | +276.11% | 10 | Feb 22, 2024 | |
| ABT Abbott Laboratories | Maintains: Overweight | $116 → $121 | $117.76 | +2.75% | 3 | Dec 13, 2023 | |
| PODD Insulet | Maintains: Overweight | $375 → $300 | $262.93 | +14.10% | 2 | Aug 9, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $30.81 | +166.15% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $191.71 | +29.36% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $224.00 | +22.77% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $547.87 | -38.12% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $7.30 | -79.44% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $6.79 | +297.64% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $124 → $111 | $110.22 | +0.71% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $72.83 | +97.38% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $144.00 | -61.11% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $105.33 | -29.74% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $70.48 | +8.78% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $17.73 | +407.61% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $84.72 | - | 1 | Dec 12, 2019 |
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $9.70
Upside: +106.19%
Nevro
Feb 22, 2024
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $4.52
Upside: +276.11%
Abbott Laboratories
Dec 13, 2023
Maintains: Overweight
Price Target: $116 → $121
Current: $117.76
Upside: +2.75%
Insulet
Aug 9, 2023
Maintains: Overweight
Price Target: $375 → $300
Current: $262.93
Upside: +14.10%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $30.81
Upside: +166.15%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $191.71
Upside: +29.36%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $224.00
Upside: +22.77%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $547.87
Upside: -38.12%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $7.30
Upside: -79.44%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $6.79
Upside: +297.64%
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $110.22
Upside: +0.71%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $72.83
Upside: +97.38%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $144.00
Upside: -61.11%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $105.33
Upside: -29.74%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $70.48
Upside: +8.78%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $17.73
Upside: +407.61%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $84.72
Upside: -